NCT05005013

A Teleheath tDCS Approach to Decrease Cannabis Use

A Teleheath tDCS Approach to Decrease Cannabis Use: Towards Reducing Multiple Sclerosis Disability

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: NYU Langone Health · Academic / Other
• Sex: Female
• Age: 21 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The study aims to evaluate the effect of Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) in decreasing distress and cannabis use. 46 participants with Relapse Remitting Multiple Sclerosis (RRMS), Cannabis Use Disorder (CUD) and elevated distress (K10 score of 10-35) will be recruited.

Conditions

• Cannabis Use Disorder
• Multiple Sclerosis

Interventions

Type	Name	Description
OTHER	Transcranial Direct Current Stimulation (tDCS)	tDCS is noninvasive brain stimulation device that modulates brain activity by delivering a low-intensity electrical current (2.0 mA) through sponge electrodes placed on the scalp.
OTHER	Sham - Transcranial Direct Current Stimulation (tDCS)	The tDCS device is programmed to mimic active tDCS.
OTHER	Mindfulness	Participants will follow an audio track for guided mindfulness during the stimulation.

Timeline

• Start date: 2022-09-13
• Primary completion: 2024-02-14
• Completion: 2024-05-22
• First posted: 2021-08-13
• Last updated: 2025-06-24
• Results posted: 2025-06-24

Locations

1 site across 1 country: United States